What We're Reading: Presidential Campaigns and the Cost of Medicine
Expansion "Gap" Puts Coverage Off Limits to 10% of Remaining Uninsured
Cancer Can Cause Heart Failure
10 Cancer Researchers Can Receive $7.5 Million in Funds
Fraud or Poverty? What Accounts for High Medicare Spending?
What We're Reading: Health Insurance Coverage and Unecessary Procedures
Now a New Companion Diagnostic for Nivolumab in Non-Squamous NSCLC
Patient Satisfaction Tied to Readiness to Leave Hospital
Identifying High-Price, Low-Price Healthcare Markets
This Week in Managed Care: October 10, 2015
Older COPD Patients May Be Using Opioids Excessively
Daraprim Price Has Yet to Be Reduced Following 5000% Increase
Can Cancer Survival Outcomes Help You Choose Your Site of Care?
Nivolumab Receives Extended Approval for Advanced Lung Cancer
What's Driving Healthcare Spending? It's the Drugs, New Data Show
NICE Believes Pembrolizumab Is Worth It in Treatment-Naïve Melanoma Patients
5 Things to Know About the New Cholesterol Drugs
Patients Exposed to Hepatitis, HIV After Unsafe Injection Practices
HIPAA Aside, Healthcare Practitioners Need to Rethink Patient Privacy
COPD Diagnoses Could Be Hastened by New Tool
Pioneer in Cancer Immunotherapy Receives Federal Award
Cost of Kidney Failure Next in CMS' Crosshairs With New ACO Model
Successful Ovarian Tissue Transplants Bring Promise of Fertility in Cancer Survivors
Food Politics Get Heated as Dietary Guidelines Near Approval
Access to Palliative Care Remains Inadequate, Report Finds
Smaller Tumors Mean Better Breast Cancer Survival: Dutch Study
Avelumab Receives Fast-Track for Merkel Cell Carcinoma
The Price Is Right? Not for Mammograms
HHS Issues Rules to Simplify EHR Requirements for Providers
Express Scripts Will Cover Both PCSK9 Inhibitors